Mankind Pharma eyes ₹9,000 cr via debt to stitch BSV deal
Mumbai: Mankind Pharma Ltd, India's fourth-largest pharmaceutical company by market share, is set to raise more than ₹9,000 crore through a mix of non-convertible debentures (NCDs) and short-term commercial ...
